MA41558B1 - Compositions d'allergènes mélangés et leurs procédés d'utilisation - Google Patents
Compositions d'allergènes mélangés et leurs procédés d'utilisationInfo
- Publication number
- MA41558B1 MA41558B1 MA41558A MA41558A MA41558B1 MA 41558 B1 MA41558 B1 MA 41558B1 MA 41558 A MA41558 A MA 41558A MA 41558 A MA41558 A MA 41558A MA 41558 B1 MA41558 B1 MA 41558B1
- Authority
- MA
- Morocco
- Prior art keywords
- allergen
- mixed allergen
- methods
- mixed
- allergen compositions
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne des compositions d'allergènes mélangés de deux ou de plus de deux allergènes différents. Dans certains cas, les compositions d'allergènes mélangés comprennent : un allergène à base de noix, un allergène à base d'animal ; et au moins un élément parmi : un allergène de plante autre que type noix ; un agent biotique ; et une vitamine. L'invention concerne également des procédés d'administration des compositions d'allergènes mélangés à un sujet. Les compositions d'allergènes mélangés trouvent une utilisation dans un grand nombre d'applications, notamment le maintien de la santé, l'équilibre immunitaire, l'équilibre digestif, le soutien immunitaire, l'amélioration de la santé, et des applications thérapeutiques.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562119014P | 2015-02-20 | 2015-02-20 | |
PCT/US2016/018731 WO2016134291A2 (fr) | 2015-02-20 | 2016-02-19 | Compositions d'allergènes mélangés et leurs procédés d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
MA41558A MA41558A (fr) | 2017-12-26 |
MA41558B1 true MA41558B1 (fr) | 2023-02-28 |
Family
ID=56689334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA41558A MA41558B1 (fr) | 2015-02-20 | 2016-02-19 | Compositions d'allergènes mélangés et leurs procédés d'utilisation |
Country Status (23)
Country | Link |
---|---|
US (4) | US10064936B2 (fr) |
EP (2) | EP4186521A1 (fr) |
JP (3) | JP6859261B2 (fr) |
KR (1) | KR20170117562A (fr) |
CN (2) | CN107405394B (fr) |
AU (2) | AU2016219793C1 (fr) |
BR (1) | BR112017017894A2 (fr) |
CA (1) | CA2977127A1 (fr) |
DK (1) | DK3258962T3 (fr) |
ES (1) | ES2937287T3 (fr) |
FI (1) | FI3258962T3 (fr) |
HK (1) | HK1247854A1 (fr) |
HU (1) | HUE061576T2 (fr) |
IL (1) | IL253976B1 (fr) |
LT (1) | LT3258962T (fr) |
MA (1) | MA41558B1 (fr) |
MX (2) | MX2017010697A (fr) |
PL (1) | PL3258962T3 (fr) |
PT (1) | PT3258962T (fr) |
RS (1) | RS63941B1 (fr) |
SG (2) | SG11201706734SA (fr) |
SI (1) | SI3258962T1 (fr) |
WO (1) | WO2016134291A2 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
CN107405394B (zh) | 2015-02-20 | 2021-12-14 | 斯坦福大学托管董事会 | 混合变应原组合物及其使用方法 |
US10143742B2 (en) * | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
WO2016138030A2 (fr) * | 2015-02-23 | 2016-09-01 | Antera Therapeutics Inc. | Compositions et procédés induisant la tolérance du système immunitaire à des allergènes |
US10856567B2 (en) | 2016-07-22 | 2020-12-08 | Kari Brown | Baby food products containing allergenic proteins and methods of delivering same |
JP7339886B2 (ja) * | 2016-11-21 | 2023-09-06 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 液体アレルゲン組成物及びその製造方法 |
US10656145B2 (en) | 2016-12-09 | 2020-05-19 | General Mills, Inc. | Detection of allergens using surface-enhanced raman scattering |
CA3050093A1 (fr) * | 2017-01-13 | 2018-07-19 | Aimmune Therapeutics, Inc. | Procedes de fabrication de farines de noix et formulations pour immunotherapie orale |
FR3062797A1 (fr) * | 2017-02-10 | 2018-08-17 | Centre Hospitalier Et Universitaire De Clermont-Ferrand | Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide |
US20180360951A1 (en) * | 2017-06-20 | 2018-12-20 | Evros Vassiliou | Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d |
US11382934B2 (en) * | 2017-07-18 | 2022-07-12 | Before Brands, Inc. | Methods for making mixed allergen compositions |
WO2019112808A1 (fr) | 2017-12-06 | 2019-06-13 | Prollergy Corporation | Composition et procédé pour la réduction de la réaction allergique |
EP3886899A1 (fr) * | 2018-11-30 | 2021-10-06 | Alladapt Immunotherapeutics, Inc. | Procédés de production de compositions d'allergènes mixtes |
EP3897170A1 (fr) * | 2018-12-21 | 2021-10-27 | Société des Produits Nestlé S.A. | Compositions buvables pour nourrissons |
WO2020154476A1 (fr) | 2019-01-23 | 2020-07-30 | Before Brands, Inc. | Procédés de fabrication de compositions d'allergènes mixtes |
US20200236982A1 (en) * | 2019-01-28 | 2020-07-30 | Lil Mixins, Llc | Tree nut powder formulation |
US11324247B2 (en) | 2019-06-13 | 2022-05-10 | Lil Mixins, Llc | Food products for infants and babies and method of making same |
US11154082B2 (en) | 2019-06-13 | 2021-10-26 | Lil Mixins, Llc | Egg product for infants and babies and method of making same |
US20240151702A1 (en) * | 2021-03-05 | 2024-05-09 | Societe Des Produits Nestle S.A. | Methods of making and assessing allergenic tree nut compositions |
US11154081B1 (en) | 2021-03-16 | 2021-10-26 | Lil Mixins, Llc | Well cooked egg powder |
US11439173B1 (en) | 2021-09-22 | 2022-09-13 | Lil Mixins, Llc | Low allergenicity well cooked food powder |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031199A (en) | 1972-12-11 | 1977-06-21 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Process for the production of allergen-containing extracts |
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
GB9323483D0 (en) | 1993-11-13 | 1994-01-05 | Cerestar Holding Bv | Edible composition and a process for its preparation |
AU1951201A (en) | 1999-12-06 | 2001-06-12 | Mount Sinai School Of Medicine Of The City University Of New York, The | Peptide antigens |
US6716471B2 (en) | 2000-05-12 | 2004-04-06 | Sigmund Kramer | Peanut powder compositions and methods of making same |
FR2822709B1 (fr) | 2001-03-30 | 2007-01-19 | Antialis | Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique |
ATE503494T1 (de) | 2003-06-23 | 2011-04-15 | Biotech Tools Sa | Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin |
US7595081B1 (en) | 2003-10-17 | 2009-09-29 | Bellar Willis F | Non-flour containing baked and related food compositions |
EP1718331A4 (fr) | 2004-02-06 | 2009-11-11 | Greer Lab Inc | Procedes et compositions pour le dosage d'allergenes |
CA2643925A1 (fr) * | 2006-02-27 | 2007-08-30 | South Georgia Pecan Company | Composition alimentaire pour animaux comprenant de la coquille de noix |
EP1872792A1 (fr) | 2006-06-29 | 2008-01-02 | Biotech Tools S.A. | Méthode pour la production d'un allergène hydrolysé |
CN101646418B (zh) * | 2006-10-12 | 2013-07-17 | 昆士兰大学 | 调节免疫应答的组合物和方法 |
US8709413B2 (en) | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
EP2224953A1 (fr) | 2008-01-02 | 2010-09-08 | Biotech Tools S.A. | Formulation pharmaceutique pour préparation d'allergènes |
EP3097927B1 (fr) | 2008-02-01 | 2023-05-03 | Murdoch Childrens Research Institute | Procédé d'induction de tolérance à un allergène |
EP2140880B1 (fr) | 2008-07-04 | 2012-11-14 | HAL Allergy Holding B.V. | Modification d'allergènes |
US8802056B2 (en) | 2008-07-17 | 2014-08-12 | John Shea | Method for testing and treating delayed food allergies |
JP5805363B2 (ja) | 2009-06-26 | 2015-11-04 | 和興フィルタテクノロジー株式会社 | 可溶性凝集体、免疫寛容誘導剤及びその製造方法 |
IN2012DN00878A (fr) * | 2009-08-18 | 2015-05-22 | Nestec Sa | |
EP2475382B1 (fr) * | 2009-09-07 | 2015-01-14 | DBV Technologies | Méthode de traitement d'oesophagite éosinophile |
CN102048077A (zh) | 2009-10-30 | 2011-05-11 | 梁振 | 一种方便营养果丁豆花 |
CN107184971A (zh) | 2010-04-30 | 2017-09-22 | 艾洛维特有限责任公司 | 经由口腔粘膜变应性脱敏的方法、制品和试剂盒 |
EP2563390A4 (fr) * | 2010-04-30 | 2014-05-14 | Allovate Llc | Procédes et articles de prévention ou de réduction du risque de développement d'un système immunitaire hyperallergénique |
GB201009368D0 (en) | 2010-06-04 | 2010-07-21 | Sana Pharma As | Dietary formulations |
EP2987501A1 (fr) | 2010-10-15 | 2016-02-24 | Alk-Abelló A/S | Suppression de l'hypersensibilité de la réponse immunitaire à un antigène étranger dérivé de matière première allergène |
GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
CN102986802A (zh) | 2012-12-11 | 2013-03-27 | 崔杰 | 一种花生核桃咸饼的制作方法 |
AU2014240404B2 (en) | 2013-03-14 | 2016-07-21 | Societe Des Produits Nestle S.A. | Manufacture of peanut formulations for oral desensitization |
WO2014159609A1 (fr) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Préparations à base d'arachide et leurs utilisations |
CN105120898A (zh) | 2013-03-19 | 2015-12-02 | 生物技术工具公司 | 过敏原制剂 |
US20150050301A1 (en) | 2013-06-06 | 2015-02-19 | Anergis S.A. | Contiguous Overlapping Peptides for Treatment of House Dust Mites Allergy |
US10485867B2 (en) | 2013-09-19 | 2019-11-26 | Allovate, Llc | Toothpaste for delivery of allergens to oral mucosa |
EP2952200A1 (fr) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergène pour le traitement prophylactique d'une allergie |
KR102425265B1 (ko) | 2014-08-25 | 2022-07-26 | 에이뮨 테라퓨틱스, 인코퍼레이티드 | 난 단백질 제형 및 이의 제조 방법 |
CN104273238A (zh) | 2014-09-27 | 2015-01-14 | 合肥市凤落河豆制食品有限公司 | 一种芝麻酱干及其制备方法 |
CN107405394B (zh) | 2015-02-20 | 2021-12-14 | 斯坦福大学托管董事会 | 混合变应原组合物及其使用方法 |
US11452774B2 (en) * | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10149904B2 (en) * | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10166286B2 (en) * | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
WO2016138030A2 (fr) | 2015-02-23 | 2016-09-01 | Antera Therapeutics Inc. | Compositions et procédés induisant la tolérance du système immunitaire à des allergènes |
-
2016
- 2016-02-19 CN CN201680017213.2A patent/CN107405394B/zh active Active
- 2016-02-19 CN CN202111381997.6A patent/CN114129720A/zh active Pending
- 2016-02-19 EP EP22204813.4A patent/EP4186521A1/fr active Pending
- 2016-02-19 KR KR1020177026057A patent/KR20170117562A/ko not_active IP Right Cessation
- 2016-02-19 MA MA41558A patent/MA41558B1/fr unknown
- 2016-02-19 EP EP16753171.4A patent/EP3258962B1/fr active Active
- 2016-02-19 LT LTEPPCT/US2016/018731T patent/LT3258962T/lt unknown
- 2016-02-19 IL IL253976A patent/IL253976B1/en unknown
- 2016-02-19 FI FIEP16753171.4T patent/FI3258962T3/fi active
- 2016-02-19 SG SG11201706734SA patent/SG11201706734SA/en unknown
- 2016-02-19 WO PCT/US2016/018731 patent/WO2016134291A2/fr active Application Filing
- 2016-02-19 PL PL16753171.4T patent/PL3258962T3/pl unknown
- 2016-02-19 CA CA2977127A patent/CA2977127A1/fr active Pending
- 2016-02-19 DK DK16753171.4T patent/DK3258962T3/da active
- 2016-02-19 BR BR112017017894A patent/BR112017017894A2/pt active Search and Examination
- 2016-02-19 RS RS20230085A patent/RS63941B1/sr unknown
- 2016-02-19 PT PT167531714T patent/PT3258962T/pt unknown
- 2016-02-19 AU AU2016219793A patent/AU2016219793C1/en active Active
- 2016-02-19 MX MX2017010697A patent/MX2017010697A/es unknown
- 2016-02-19 SG SG10201909093X patent/SG10201909093XA/en unknown
- 2016-02-19 ES ES16753171T patent/ES2937287T3/es active Active
- 2016-02-19 HU HUE16753171A patent/HUE061576T2/hu unknown
- 2016-02-19 JP JP2017544020A patent/JP6859261B2/ja active Active
- 2016-02-19 SI SI201631663T patent/SI3258962T1/sl unknown
- 2016-02-19 US US15/048,609 patent/US10064936B2/en active Active
- 2016-11-09 US US15/347,260 patent/US9731003B2/en active Active
-
2017
- 2017-08-18 MX MX2022008663A patent/MX2022008663A/es unknown
-
2018
- 2018-05-25 US US15/989,741 patent/US20190038741A1/en not_active Abandoned
- 2018-06-07 HK HK18107460.6A patent/HK1247854A1/zh unknown
-
2020
- 2020-12-24 JP JP2020215128A patent/JP2021046445A/ja active Pending
-
2021
- 2021-07-23 US US17/384,628 patent/US20220133882A1/en active Pending
-
2022
- 2022-03-11 AU AU2022201699A patent/AU2022201699A1/en active Pending
- 2022-07-11 JP JP2022110965A patent/JP2022125346A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA41558B1 (fr) | Compositions d'allergènes mélangés et leurs procédés d'utilisation | |
MA43187B1 (fr) | Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations | |
EA201791702A1 (ru) | Терапевтические средства на основе гликанов и связанные с ними способы | |
WO2016060996A3 (fr) | Compositions d'interleukine-15 et leurs utilisations | |
MA51747A (fr) | Formulation d'anticorps pharmaceutique à ph faible | |
BR112015023391A2 (pt) | formulações compreendendo conjugado droga-anticorpo anti-egfr | |
CY1115082T1 (el) | Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων | |
PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
NO20070580L (no) | Behandling av cancer. | |
MA46685A (fr) | Extrait d'une composition à base de plantes médicinales en tant qu'agent antimicrobien et/ou antibiofilm | |
FR3058059B1 (fr) | Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine. | |
BR112018013084A2 (pt) | tratamentos de combinação compreendendo a administração de imidazopirazinonas | |
MA45450B1 (fr) | Formulations d'anticorps anti-cd19 | |
ATE455096T1 (de) | Biaromatische verbindungen die ppar-gamma rezeptoren aktivieren und deren anwendungen in kosmetischen oder pharmazeutischen zusammensetzungen | |
CY1124115T1 (el) | Η χρηση τριβενζοϊκου γλυκερυλιου που περιεχει συνθεση σε νευροεκφυλιστικες διαταραχες | |
BR112017002796A2 (pt) | método de induzir saciedade | |
SV2003000712A (es) | Dispositivos y metodos para aplicacion vertida ref. 497363sv:ssi | |
MA54936A (fr) | Triamtérène ou nolatrexed destinés à être utilisés dans le traitement de la phénylcétonurie | |
HN2004000526A (es) | Hormonas de administracion transdermica que no necesitan potenciadores de penetracion | |
BR112021014566A2 (pt) | Moduladores de gpr35 | |
FR3031104B1 (fr) | Composition pro-pheromonale apaisante pour les mammiferes | |
FR3086172B1 (fr) | Formulation cosmetique | |
MA41102A (fr) | Compositions contenant de la curcumine à biodisponibilité améliorée | |
BR112017017685A2 (pt) | formulações farmacêuticas de inibidor de c1 esterase |